Hyperammonemia is mainly found in hepatic encephalopathy
and in genetic defects of the urea cycle or
other pathways of the intermediary metabolism. Clinically
a difference has to be made between chronic
moderate hyperammonemia and acutely increased
concentrations. Pathogenetic mechanisms of ammonia
toxicity to the brain are partly unraveled. In some
animal models confounding variables, such as the reduced
intake of food and amino acid imbalance due to
liver insufficiency, do not allow to establish unequivocal
causal relationships between the ammonia concentration
and measured effects. In chronic moderate
hyperammonemia an increased flux through the serotonin
pathway is a key factor. It is caused by an
increased transport of large neutral amino acids (including
tryptophan) through the blood-brain barrier,
accentuated by the imbalance of plasma amino acids
in hepatic insufficiency. It is stimulated by D- or L-glutamine.
Evidence is presented showing that a functioning
?-glutamyl cycle (glutathione formation) is a prerequisite.
In acute hyperammonemia involvement of
NMDA receptors, glutamate, NO and cGMP plays an
additional role. In hyperammonemic crises the increased
cerebral blood flow leads to brain edema; factors
discussed here are increased osmolytes in astrocytes
and serotoninergic activity. Recent data indicate
that axonal development is affected by ammonia and
can be normalized
Print ISSN: 1434-6621
Volume: 40, 07/2002
Pages: 653 - 662